These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 35482831)

  • 1. New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis.
    Aldred MA; Morrell NW; Guignabert C
    Circ Res; 2022 Apr; 130(9):1365-1381. PubMed ID: 35482831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of genetics in pulmonary arterial hypertension.
    Ma L; Chung WK
    J Pathol; 2017 Jan; 241(2):273-280. PubMed ID: 27770446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic basis of pulmonary arterial hypertension.
    Ma L; Chung WK
    Hum Genet; 2014 May; 133(5):471-9. PubMed ID: 24442418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.
    Gilbane AJ; Derrett-Smith E; Trinder SL; Good RB; Pearce A; Denton CP; Holmes AM
    Am J Respir Crit Care Med; 2015 Mar; 191(6):665-77. PubMed ID: 25606692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging biologics for the treatment of pulmonary arterial hypertension.
    Hye T; Hossain MR; Saha D; Foyez T; Ahsan F
    J Drug Target; 2023 Jun; 31(5):1-15. PubMed ID: 37026714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Bone Morphogenetic Protein Receptor Type 2 (
    Devendran A; Kar S; Bailey R; Trivieri MG
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
    Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
    Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor.
    Davies RJ; Morrell NW
    Chest; 2008 Dec; 134(6):1271-1277. PubMed ID: 19059957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M; Gomez-Puerto MC; Ten Dijke P
    Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary artery hypertension in childhood: The transforming growth factor-β superfamily-related genes.
    Yuan SM
    Pediatr Neonatol; 2018 Apr; 59(2):112-119. PubMed ID: 28967497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New insights in the pathogenesis of pulmonary arterial hypertension].
    Bordenave J; Tu L; Savale L; Huertas A; Humbert M; Guignabert C
    Rev Mal Respir; 2019 Apr; 36(4):433-437. PubMed ID: 31010759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation in Pulmonary Arterial Hypertension.
    Klouda T; Yuan K
    Adv Exp Med Biol; 2021; 1303():351-372. PubMed ID: 33788202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic pulmonary hypertension: what did we learn from genes?
    Sztrymf B; Yaïci A; Jaïs X; Sitbon O; Simonneau G; Humbert M
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S91-100. PubMed ID: 16457021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key role of the endothelial TGF-β/ALK1/endoglin signaling pathway in humans and rodents pulmonary hypertension.
    Gore B; Izikki M; Mercier O; Dewachter L; Fadel E; Humbert M; Dartevelle P; Simonneau G; Naeije R; Lebrin F; Eddahibi S
    PLoS One; 2014; 9(6):e100310. PubMed ID: 24956016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New progress in diagnosis and treatment of pulmonary arterial hypertension.
    Zhang ZQ; Zhu SK; Wang M; Wang XA; Tong XH; Wan JQ; Ding JW
    J Cardiothorac Surg; 2022 Aug; 17(1):216. PubMed ID: 36038916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic framework underlying pulmonary arterial hypertension.
    Southgate L; Machado RD; Gräf S; Morrell NW
    Nat Rev Cardiol; 2020 Feb; 17(2):85-95. PubMed ID: 31406341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease.
    Long L; Crosby A; Yang X; Southwood M; Upton PD; Kim DK; Morrell NW
    Circulation; 2009 Feb; 119(4):566-76. PubMed ID: 19153267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of genetic mutations in pulmonary arterial hypertension.
    Garcia-Rivas G; Jerjes-Sánchez C; Rodriguez D; Garcia-Pelaez J; Trevino V
    BMC Med Genet; 2017 Aug; 18(1):82. PubMed ID: 28768485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Treatment Pathways in Pulmonary Arterial Hypertension.
    Qaiser KN; Tonelli AR
    Methodist Debakey Cardiovasc J; 2021; 17(2):106-114. PubMed ID: 34326930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
    Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
    Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.